TY - JOUR
T1 - Determinants of sudden cardiac death in adult patients with eisenmenger syndrome
AU - Chiriac, Anca
AU - Riley, David C.
AU - Russell, Matthew
AU - Moore, Jeremy P.
AU - Padmanabhan, Deepak
AU - Hodge, David O.
AU - Spiegel, Matthew R.
AU - Vargas, Emily R.
AU - Phillips, Sabrina D.
AU - Ammash, Naser M.
AU - Madhavan, Malini
AU - Asirvatham, Samuel J.
AU - McLeod, Christopher J.
N1 - Funding Information:
This work was supported by a grant from the Mayo Clinic Cardiovascular Department.
Publisher Copyright:
© 2020 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley.
PY - 2020
Y1 - 2020
N2 - BACKGROUND: Patients with Eisenmenger syndrome are known to have a high incidence of sudden cardiac death (SCD), yet the underlying causes are not well understood. We sought to define the predictors of SCD in this population. METHODS AND RESULTS: A retrospective analysis of all patients with Eisenmenger syndrome from 2 large tertiary referral cent-ers was performed. ECGs, prolonged ambulatory recordings, echocardiograms, and clinical histories were reviewed; and the cause of death was identified. A total of 246 patients (85 [34.6%] men) with a mean age of 37.3 (±14.2) years were followed up for a median of 7 years. Over the study period, 136 patients died, with 40 experiencing SCD and 74 experiencing cardiac death (sudden and nonsudden). Age, atrial fibrillation, prolonged QRS duration, complete heart block, right atrial enlargement, right bundle branch block, increased right atrial pressure, impaired biventricular function, and the presence of a pacemaker were associated with increased risk of SCD, whereas advanced pulmonary hypertension therapies were protective. Atrial fibrillation (11.45-fold increased risk; P<0.001) and QRS duration ≥120 ms (2.06-fold increased risk; P=0.034) remained sig-nificant predictors of SCD in the multivariate analysis, whereas advanced pulmonary hypertension therapies were strongly protective against SCD (P<0.001). CONCLUSIONS: Atrial arrhythmias, impaired ventricular function, and conduction system disease were associated with increased risk of SCD in this cohort of patients with Eisenmenger syndrome, providing an opportunity for early risk stratification and potential intervention. Clinical heart failure symptoms (New York Heart Association class ≥II) were predictive of increased mortality but not of SCD, suggesting a potential arrhythmic cause behind SCD.
AB - BACKGROUND: Patients with Eisenmenger syndrome are known to have a high incidence of sudden cardiac death (SCD), yet the underlying causes are not well understood. We sought to define the predictors of SCD in this population. METHODS AND RESULTS: A retrospective analysis of all patients with Eisenmenger syndrome from 2 large tertiary referral cent-ers was performed. ECGs, prolonged ambulatory recordings, echocardiograms, and clinical histories were reviewed; and the cause of death was identified. A total of 246 patients (85 [34.6%] men) with a mean age of 37.3 (±14.2) years were followed up for a median of 7 years. Over the study period, 136 patients died, with 40 experiencing SCD and 74 experiencing cardiac death (sudden and nonsudden). Age, atrial fibrillation, prolonged QRS duration, complete heart block, right atrial enlargement, right bundle branch block, increased right atrial pressure, impaired biventricular function, and the presence of a pacemaker were associated with increased risk of SCD, whereas advanced pulmonary hypertension therapies were protective. Atrial fibrillation (11.45-fold increased risk; P<0.001) and QRS duration ≥120 ms (2.06-fold increased risk; P=0.034) remained sig-nificant predictors of SCD in the multivariate analysis, whereas advanced pulmonary hypertension therapies were strongly protective against SCD (P<0.001). CONCLUSIONS: Atrial arrhythmias, impaired ventricular function, and conduction system disease were associated with increased risk of SCD in this cohort of patients with Eisenmenger syndrome, providing an opportunity for early risk stratification and potential intervention. Clinical heart failure symptoms (New York Heart Association class ≥II) were predictive of increased mortality but not of SCD, suggesting a potential arrhythmic cause behind SCD.
KW - Atrial fibrillation
KW - Cardiac arrhythmia
KW - Congenital heart disease
KW - Congestive heart failure
KW - Eisenmenger syndrome
KW - Sudden cardiac death
UR - http://www.scopus.com/inward/record.url?scp=85082003938&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85082003938&partnerID=8YFLogxK
U2 - 10.1161/JAHA.119.014554
DO - 10.1161/JAHA.119.014554
M3 - Article
C2 - 32174228
AN - SCOPUS:85082003938
SN - 2047-9980
VL - 9
JO - Journal of the American Heart Association
JF - Journal of the American Heart Association
IS - 6
M1 - e014554
ER -